Back
Artiva Biotherapeutics 10K Form
Sell
31
ARTV
Artiva Biotherapeutics
Last Price:
$11.13
Seasonality Move:
--
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ARTV News And Ratings
See the #1 stock for the next 7 days that we like better than ARTV
ARTV Financial Statistics
Sales & Book Value
Annual Sales: | $33.5M |
---|---|
Cash Flow: | $-15.1M |
Price / Cash Flow: | 0 |
Annual Sales: | $-9.93 |
Price / Book: | 0 |
Profitability
EPS (TTM): | -3.08220 |
---|---|
Net Income (TTM): | $-54.2M |
Gross Margin: | -- |
Return on Equity: | 0% |
Return on Assets: | -38.54% |
Artiva Biotherapeutics Earnings Forecast
Key Artiva Biotherapeutics Financial Ratios
-
The Research & Development expenses have been 150.04% of Revenue.
-
The Interest Expense is 0.00% of Operating Income.
-
The Net Earning history of ARTV is -82.69% of Total Revenues.
-
Per Share Earnings over the last 4 years have been positive in 2 years.
Artiva Biotherapeutics Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | ARTV |
Website: | artivabio.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 6.35 |
Quick Ratio: | 6.16 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
ARTV Technical Analysis vs Fundamental Analysis
Sell
31
Artiva Biotherapeutics (ARTV)
is a Sell
Is Artiva Biotherapeutics a Buy or a Sell?
-
Artiva Biotherapeutics stock is rated a SellThe current Artiva Biotherapeutics [ARTV] share price is $11.11. The Score for ARTV is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.